Group One Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-6,876
| Closed | -$23K | – | 5830 |
|
|
2018
Q3 | $23K | Sell |
6,876
-39,446
| -85% | -$142K | ﹤0.01% | 4353 |
|
|
2018
Q2 | $174K | Buy |
+46,322
| New | +$226K | ﹤0.01% | 3165 |
|
|
2018
Q1 | – | Sell |
-129,913
| Closed | -$605K | – | 5624 |
|
|
2017
Q4 | $604K | Sell |
129,913
-93,202
| -42% | -$514K | ﹤0.01% | 2102 |
|
|
2017
Q3 | $1.58M | Buy |
223,115
+116,912
| +110% | +$841K | 0.01% | 1218 |
|
|
2017
Q2 | $768K | Sell |
106,203
-53,929
| -34% | -$337K | 0.01% | 1659 |
|
|
2017
Q1 | $986K | Sell |
160,132
-108,595
| -40% | -$595K | 0.01% | 1347 |
|
|
2016
Q4 | $1.57M | Sell |
268,727
-19,342
| -7% | -$106K | 0.02% | 1047 |
|
|
2016
Q3 | $1.53M | Buy |
288,069
+196,625
| +215% | +$1.06M | 0.02% | 991 |
|
|
2016
Q2 | $605K | Sell |
91,444
-92,734
| -50% | -$518K | 0.01% | 1597 |
|
|
2016
Q1 | $860K | Buy |
184,178
+58,890
| +47% | +$235K | 0.01% | 1288 |
|
|
2015
Q4 | $633K | Buy |
125,288
+75,439
| +151% | +$358K | 0.01% | 1626 |
|
|
2015
Q3 | $175K | Sell |
49,849
-112,572
| -69% | -$754K | ﹤0.01% | 2605 |
|
|
2015
Q2 | $1.62M | Buy |
162,421
+86,638
| +114% | +$929K | 0.02% | 875 |
|
|
2015
Q1 | $965K | Sell |
75,783
-76,717
| -50% | -$986K | 0.02% | 1114 |
|
|
2014
Q4 | $2.16M | Buy |
152,500
+146,635
| +2,500% | +$2.27M | 0.03% | 607 |
|
|
2014
Q3 | $81K | Sell |
5,865
-218,014
| -97% | -$3.34M | ﹤0.01% | 3183 |
|
|
2014
Q2 | $3.44M | Buy |
223,879
+215,919
| +2,713% | +$3.06M | 0.05% | 428 |
|
|
2014
Q1 | $136K | Sell |
7,960
-328,193
| -98% | -$4.95M | ﹤0.01% | 2775 |
|
|
2013
Q4 | $4.35M | Buy |
336,153
+108,625
| +48% | +$1.3M | 0.07% | 303 |
|
|
2013
Q3 | $2.3M | Sell |
227,528
-58,694
| -21% | -$522K | 0.04% | 487 |
|
|
2013
Q2 | $2.14M | Buy |
+286,222
| New | +$2.24M | 0.05% | 390 |
|
Group One Trading's KERX Position: Q4 2018 in Review
Group One Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 6,876 shares — an estimated $23K sold.
Group One Trading first reported a position in KERX in Q2 2013 and held it in 21 quarters. The position peaked at $4.35M in Q4 2013. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Group One Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Group One Trading sold 6,876 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $23K.
- Group One Trading first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 21 quarters.
- Group One Trading's Keryx Biopharmaceuticals Inc position peaked at $4.35M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.